SCHEMBL24701068

SCHEMBL24701068

c1ccc(N(c2ccccc2)c2ccc3c(c2)oc2c(N(c4ccccc4)c4ccccc4)c4c(oc5cc(N(c6ccccc6)c6ccccc6)ccc54)c(N(c4ccccc4)c4ccccc4)c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.36
TDP1 Q9NUW8 6/20 0.36
MAPT P10636 5/20 0.36
L3MBTL1 Q9Y468 5/20 0.36
KDM4E B2RXH2 4/20 0.36
CYP3A4 P08684 4/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 7/20 0.34
KMT2A Q03164 7/20 0.34
HPGD P15428 5/20 0.34
RECQL P46063 3/20 0.34
BLM P54132 3/20 0.34
GLA P06280 3/20 0.34
ESR1 P03372 2/20 0.34
THRB P10828 2/20 0.34
GAA P10253 2/20 0.34
HIF1A Q16665 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975285 0.92 TDP1 (0.33) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL13508052 0.85 ALDH1A1 (0.37) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL17875602 0.84 ALDH1A1 (0.42) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL13506906 0.81 ALDH1A1 (0.39) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL15197370 0.81 AHR (0.36) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL24700659 0.81 ALDH1A1 (0.35) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL12203174 0.81 ALDH1A1 (0.45) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL23975202 0.80 KDM4E (0.35) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL17658307 0.80 TDP1 (0.35) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL13508110 0.80 TDP1 (0.34) ALDH1A1TDP1MAPTL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 US disclosed
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 US disclosed
US-20220380387-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029120-B2 Organic electroluminescence element and electronic device RPS10, H1-10, OR10J3 ALDH1A1 374/4885TDP1 2504/4885MAPT 3224/4885
US-20220380387-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE H1-2, H1-0, CCNE2 ALDH1A1 1796/4885TDP1 2302/4885MAPT 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.